15.51
Overview
News
Price History
Option Chain
Financials
Why TEVA Down?
Discussions
Forecast
Stock Split
Dividend History
Teva Pharmaceutical Industries Ltd Adr stock is traded at $15.51, with a volume of 8.89M.
It is down -0.45% in the last 24 hours and up +0.91% over the past month.
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
See More
Previous Close:
$15.58
Open:
$15.53
24h Volume:
8.89M
Relative Volume:
0.73
Market Cap:
$17.76B
Revenue:
$16.54B
Net Income/Loss:
$-1.64B
P/E Ratio:
-10.70
EPS:
-1.45
Net Cash Flow:
$749.00M
1W Performance:
+8.54%
1M Performance:
+0.91%
6M Performance:
-15.89%
1Y Performance:
+10.39%
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Company Profile
Name
Teva Pharmaceutical Industries Ltd Adr
Sector
Phone
972 (3) 914-8213
Address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEL AVIV
Compare TEVA with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.51 | 17.76B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
ZTS
Zoetis Inc
|
156.40 | 67.32B | 9.26B | 2.49B | 2.30B | 5.47 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.78B | 30.25B | 1.37B | 5.08B | 0.4257 |
![]()
HLN
Haleon Plc Adr
|
10.15 | 46.14B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
UTHR
United Therapeutics Corp
|
303.09 | 13.18B | 2.76B | 1.11B | 898.10M | 22.77 |
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-10-24 | Upgrade | Argus | Hold → Buy |
Mar-08-24 | Upgrade | JP Morgan | Underweight → Neutral |
Feb-12-24 | Upgrade | Piper Sandler | Neutral → Overweight |
Jan-23-24 | Upgrade | Jefferies | Hold → Buy |
Jan-03-24 | Upgrade | Piper Sandler | Underweight → Neutral |
Dec-18-23 | Initiated | HSBC Securities | Buy |
Nov-27-23 | Upgrade | UBS | Neutral → Buy |
Jul-06-23 | Upgrade | UBS | Sell → Neutral |
May-25-23 | Initiated | Morgan Stanley | Equal-Weight |
May-18-23 | Upgrade | Evercore ISI | In-line → Outperform |
Jan-19-23 | Downgrade | Jefferies | Buy → Hold |
Nov-14-22 | Downgrade | JP Morgan | Neutral → Underweight |
Nov-04-22 | Downgrade | UBS | Neutral → Sell |
Oct-21-22 | Resumed | Jefferies | Buy |
Aug-05-22 | Upgrade | BofA Securities | Neutral → Buy |
Jun-14-22 | Resumed | UBS | Neutral |
May-17-22 | Upgrade | BofA Securities | Underperform → Neutral |
May-04-22 | Downgrade | Piper Sandler | Neutral → Underweight |
Apr-05-22 | Upgrade | Barclays | Equal Weight → Overweight |
Mar-25-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
Jan-27-22 | Downgrade | Argus | Buy → Hold |
Oct-28-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
May-04-21 | Downgrade | UBS | Buy → Neutral |
Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
Nov-25-20 | Initiated | Oppenheimer | Perform |
Aug-06-20 | Upgrade | Barclays | Underweight → Equal Weight |
Jul-27-20 | Resumed | Goldman | Neutral |
Jun-01-20 | Upgrade | SunTrust | Hold → Buy |
Apr-24-20 | Resumed | Citigroup | Neutral |
Apr-06-20 | Upgrade | UBS | Neutral → Buy |
Feb-24-20 | Downgrade | Edward Jones | Hold → Sell |
Nov-12-19 | Upgrade | JP Morgan | Underweight → Neutral |
Oct-17-19 | Upgrade | Gabelli & Co | Hold → Buy |
Aug-07-19 | Downgrade | Evercore ISI | Outperform → In-line |
Jul-19-19 | Initiated | Wolfe Research | Peer Perform |
Jul-15-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
Jul-10-19 | Resumed | Credit Suisse | Neutral |
Jul-05-19 | Upgrade | Argus | Hold → Buy |
Jun-11-19 | Initiated | Barclays | Underweight |
Jun-03-19 | Upgrade | Oppenheimer | Perform → Outperform |
May-30-19 | Downgrade | BofA/Merrill | Buy → Underperform |
May-28-19 | Downgrade | UBS | Buy → Neutral |
Mar-20-19 | Initiated | SunTrust | Hold |
Mar-07-19 | Resumed | UBS | Buy |
View All
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Latest News
There Are Mixed Signals on the Chart for Teva- Pharmaceutical Industries Ltd. ADR (TEVA) - uspostnews.com
Digi Power X Inc (DGXX)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com
Market Analysts see Norwegian Cruise Line Holdings Ltd [NCLH] gaining to $21. Time to buy? - dbtnews.com
PG&E Corp [PCG] Revenue clocked in at $24.54 billion, down -14.37% YTD: What’s Next? - dbtnews.com
Greenwave Technology Solutions Inc [GWAV] Is Currently 12.13 above its 200 Period Moving Avg: What Does This Mean? – The DBT News - dbtnews.com
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Performance and Fundamentals Dashboard tells a completely different story – Sete News - Sete News
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock: A Year of Highs and Lows - investchronicle.com
Company’s Banking Stock: Dissecting a 37.52% Quarterly Revenue Decline Amid Growth - investchronicle.com
NEOV’s Market Whiplash: -48.46% YTD Decline, 15.24% Rise in 30 Days - investchronicle.com
Adagio Medical Holdings Inc (ADGM) Stock: Uncovering a 52-Week Range and Trading Volume - investchronicle.com
A company insider recently sold 70,961 shares of Teva- Pharmaceutical Industries Ltd. ADR [TEVA]. Should You Sale? - knoxdaily.com
Introducing Our Rant Against Teva- Pharmaceutical Industries Ltd. ADR - uspostnews.com
OS overperforms with a 2.12 increase in share price - uspostnews.com
For Kopin Corp [KOPN], Analyst sees a rise to $2. What next? - dbtnews.com
Market Analysts see Geron Corp [GERN] falling to $2. Time to buy? - dbtnews.com
Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Is Currently 5.18 below its 200 Period Moving Avg: What Does This Mean? – The DBT News - dbtnews.com
The growth track for Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has changed recently - Sete News
Rezolute Inc: Weathering Stock Market Storms with 190.08M Market Cap - investchronicle.com
Ready to Jump After Recent Trade: NIO Inc ADR (NIO) - Sete News
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock: Exploring a Year of Highs, Lows, and Trading Volume - investchronicle.com
ORCL’s Stock Journey: What Investors Need to Know About Oracle Corp’s Performance - investchronicle.com
TGB Stock Update: Taseko Mines Ltd’s Banking’s Market Struggles and Potential Opportunities - investchronicle.com
Lexicon Pharmaceuticals Inc (LXRX) Stock: A Year of Market Fluctuations - investchronicle.com
HESM’s latest rating updates from top analysts. - knoxdaily.com
Analysts review Teva- Pharmaceutical Industries Ltd. ADR’s rating - knoxdaily.com
Trump Tariff Sell-Off: 3 Superb Stocks That Make for No-Brainer Buys Right Now - The Motley Fool
Zacks Industry Outlook Dr. Reddy's, Sandoz And Teva Pharmaceuticals - Barchart.com
Is Vera Therapeutics Inc (VERA) a threat to investors? - uspostnews.com
What technical indicators reveal about MYGN stock - uspostnews.com
VF Corp (VFC) is a good investment, but the stock may be overvalued - uspostnews.com
Investing in Calumet Inc (CLMT) might be an excellent idea, but the stock is currently overvalued/undervalued - uspostnews.com
Wabash National Corp (WNC) stock on the rise: An overview - uspostnews.com
The Gryphon Digital Mining Inc (GRYP) had a good session last reading, didn’t it? - uspostnews.com
Generics Industry: India Celebrates Pharmaceutical Tariffs Exemption but Uncertainty Remains High - Morningstar
What will the future hold for CarGurus Inc (NASDAQ:CARG) stock? - US Post News
TEVA’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com
Teva Pharmaceutical Stock Scores RS Rating Upgrade - MSN
IBD Rating Upgrades: Teva Pharmaceutical ADR Flashes Improved Relative Price Strength - Investor's Business Daily
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
How does TEVA’s price to cash per share ratio compare in the market? - US Post News
Teva Pharmaceutical Industries Limited Sponsored ADR to Host Earnings Call - ACCESS Newswire
Validea Detailed Fundamental AnalysisTEVA - Nasdaq
Why weight-loss drugs are the top target of Medicare price negotiations - Equities News
Investor Network: Teva Pharmaceutical Industries Limited Sponsored ADR to Host Earnings Call - ACCESS Newswire
Is the SM Energy Co (NYSE:SM) stock an investment opportunity? - US Post News
Teva Pharmaceutical Stock: Strategic Global Access Initiatives Advance - sharewise
Are Clear Secure Inc’shares a good deal? - US Post News
Molina Healthcare Inc (MOH) stock on the rise: An overview - US Post News
Stocktwits teva sales - Texas is Life
Teva- Pharmaceutical Industries Ltd. ADR’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle
FHN’s Stock Market Expedition: Traversing Gains and Losses in 2023 - The InvestChronicle
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):